The FY2025 (Dec) proxy of Liquidia names 14 peer companies for pay. Pay versus performance data of Liquidia for that year is not on file, so it has no rank.
Pay peer group, FY2025 (Dec) proxy
| Kiniksa Pharmaceuticals International | ||
| Mirum Pharmaceuticals | ||
| Travere Therapeutics | ||
| Amphastar Pharmaceuticals | ||
| Agios Pharmaceuticals | ||
| Arcturus Therapeutics Holdings Inc. | Not disclosed | Not disclosed |
| Axsome Therapeutics | Not disclosed | Not disclosed |
| Biocryst Pharmaceuticals | Not disclosed | Not disclosed |
| Catalyst Pharmaceuticals, Inc. | Not disclosed | Not disclosed |
| Mannkind | Not disclosed | Not disclosed |
| Pacira BioSciences | Not disclosed | Not disclosed |
| Rhythm Pharmaceuticals | Not disclosed | Not disclosed |
| Theravance Biopharma, Inc. | Not disclosed | Not disclosed |
| Verona Pharma Plc | Not disclosed | Not disclosed |
14 companies
Changes by year
No proxy on file names a change to the peer group.
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.